Medical Condition News

RSS

Eating Disorder Hope partners with MyPyramid to help eating disorder sufferers

Eating Disorder Hope, a respected independent resource for sufferers of anorexia, bulimia and overeating disorders, has partnered with MyPyramid to help eating disorder sufferers find nutritional and healthy lifestyle support.

24 Nov 2010

Study finds solution for debate about mutation testing to prevent children with cystic fibrosis

Testing for genetic mutations beyond those medically recommended is unlikely to prevent the birth of children with classic cystic fibrosis and may detect mutations causing only mild disease, according to a study published online in Genetics in Medicine, the official publication of the American College of Medical Genetics (ACMG).

From Quest Diagnostics 24 Nov 2010

Testing less frequently not a good way to economize for people living with diabetes

The American economy is struggling— and people living with diabetes are feeling the brunt of the rising prices of medical supplies and doctor visit co-pays. In a recent poll by dLife.com, more than 400 people living with diabetes revealed they struggle when it comes to paying for diabetic supplies.

24 Nov 2010

Provectus reports progress in PV-10 program for metastatic melanoma

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, reports continued progress in its compassionate use program for PV-10. The program currently has enrolled more than 40 patients, ten of whom are expanded access patients from the company's Phase 2 trial of PV-10 for metastatic melanoma, as well as more than 30 new patients.

24 Nov 2010

Hepcidin hormone may be potential therapeutic tool for anemic blood disorders

A hormone made by the body may be a potential therapeutic tool for the treatment of two anemic blood disorders beta-thalassemia and hemochromatosis. The new research was led by scientists at Weill Cornell Medical College and published in the Journal of Clinical Investigation and the journal Blood.

24 Nov 2010

Amorfix introduces high affinity antibodies against cancer primary cells

Amorfix Life Sciences, a product development company focused on diagnostics and therapeutics for misfolded protein diseases, today announced that together with its partner Epitomics, high affinity antibodies to prion protein disease specific epitopes (DSEs) have been produced, which bind preferentially to several cancer primary cells and tumor cell lines, but not normal cells.

24 Nov 2010

Pathological gamblers more likely to commit suicide

Pathological gamblers are risking more than their money, they are also three times more likely to commit suicide than non-betters. A new Montreal inter-university study has shown these gamblers are also plagued by personality disorders. These findings, published in a recent issue of the Psychology of Addictive Behaviors, may have implications for developing improved targeted suicide prevention programs.

24 Nov 2010

Researchers find link between acrolein and multiple sclerosis

Researchers have found evidence that an environmental pollutant may play an important role in causing multiple sclerosis and that a hypertension drug might be used to treat the disease.

24 Nov 2010

More salt in many holiday meals, cardiologist warns

There can be far more salt in many holiday meals than people realize, and the proof can be found at hospital emergency rooms. Heart problems aggravated or unmasked after ingestion of a significant amount of salt tend to make holidays such as Thanksgiving, Passover and Christmas very busy times for health providers like University of Medicine and Dentistry of New Jersey (UMDNJ) cardiologist Marc Klapholz, M.D., F.A.C.C.

24 Nov 2010

New IQQA Suite provides total solutions for liver cancer diagnosis, operative treatment management

EDDA Technology Introduces IQQA-Liver Suite To Provide Dedicated Total Solutions For Liver Cancer Diagnosis And Treatment Management

24 Nov 2010

Magnetic fluid hyperthermia destroys cells inside tumors

Magnetic fluid hyperthermia (MFH) is a promising new cancer treatment that essentially "fries" cells inside tumors. The procedure has been used successfully in prostate, liver, and breast tumors.

24 Nov 2010

New genomic approach to evaluate suspicious thyroid nodules

Doctors at the University of Colorado School of Medicine were concerned recently when they found a nodule in the thyroid of a 64-year-old Colorado man. They extracted cells from the nodule, hoping to determine whether the man had cancer. But the biopsy results were inconclusive.

24 Nov 2010

Lifestyle-related diseases will be costly down the road; Americans rate their healthcare highly

Increased efforts to prevent several lifestyle-related diseases could save the United States billions of dollars a year in medical costs, according to a study scheduled to run in the American Journal of Public Health.

24 Nov 2010

Experience of ill health associated with reduction or cessation of alcohol consumption

In a cross-sectional study from the 2004 and 2007 Australian National Drug Strategy Household (NDSH) surveys, respondents were questioned about their current and past drinking, the presence of formal diagnosis for specific diseases (heart disease, type 2 diabetes, hypertension, cancer, anxiety, depression) and self-perceived general health status. The sample sizes for the 2004 and 2007 NDSH surveys were 24,109 and 23,356, respectively.

24 Nov 2010

Less affluent cancer patients more likely to develop life-threatening health problems

CANCER patients from deprived backgrounds are more likely to develop life-threatening health problems, research published today (Wednesday) in the British Journal of Cancer shows.

24 Nov 2010

XenoPort receives grant from Michael J. Fox Foundation to support Parkinson's disease therapies

XenoPort, Inc. announced today that it has been awarded a grant from The Michael J. Fox Foundation for Parkinson's Research to support a preclinical study of the efficacy and safety of a novel, orally administered prodrug of acamprosate in reducing L-Dopa induced dyskinesias (LID) in a pre-clinical model of Parkinson's disease.

24 Nov 2010

Disrupting estrogen pathway can halt expansion of breast cancer stem cells: Research

Breast cancer stem cells (CSCs), the aggressive cells thought to be resistant to current anti-cancer therapies and which promote metastasis, are stimulated by estrogen via a pathway that mirrors normal stem cell development.

23 Nov 2010

'Telehealth' devices allow patients to track illnesses from home

Thousands of seriously ill patients are relying on computerized health trackers to help keep them safe at home.

23 Nov 2010

BioAlliance presents AMEP preclinical, phase I clinical results for melanoma at Electrochemotherapy Meeting

BioAlliance Pharma SA, a company dedicated to the supportive care and treatment of cancer patients, presented preclinical and promising preliminary phase I clinical results with its AMEP biotherapy at the "Electrochemotherapy 1st International Users' Meeting"(Bologna, Italy, November 19-20, 2010).

23 Nov 2010

FDA clears BG Medicine's Galectin-3 test to identify high risk patients with cardiovascular disease

BG Medicine, Inc., a U.S.-based life sciences company, announced today that the U.S. Food and Drug Administration has cleared the company's Galectin-3 test for use in conjunction with clinical evaluation as an aid to assess the prognosis of patients diagnosed with chronic heart failure. This marks the first time the FDA has cleared a test to measure galectin-3 blood levels, and is the first novel cardiac test cleared by the FDA in five years.

23 Nov 2010

Medical Condition News

Eating Disorder Hope partners with MyPyramid to help eating disorder sufferers

Study finds solution for debate about mutation testing to prevent children with cystic fibrosis

Testing less frequently not a good way to economize for people living with diabetes

Provectus reports progress in PV-10 program for metastatic melanoma

Hepcidin hormone may be potential therapeutic tool for anemic blood disorders

Amorfix introduces high affinity antibodies against cancer primary cells

Pathological gamblers more likely to commit suicide

Researchers find link between acrolein and multiple sclerosis

More salt in many holiday meals, cardiologist warns

New IQQA Suite provides total solutions for liver cancer diagnosis, operative treatment management

Magnetic fluid hyperthermia destroys cells inside tumors

New genomic approach to evaluate suspicious thyroid nodules

Lifestyle-related diseases will be costly down the road; Americans rate their healthcare highly

Experience of ill health associated with reduction or cessation of alcohol consumption

Less affluent cancer patients more likely to develop life-threatening health problems

XenoPort receives grant from Michael J. Fox Foundation to support Parkinson's disease therapies

Disrupting estrogen pathway can halt expansion of breast cancer stem cells: Research

'Telehealth' devices allow patients to track illnesses from home

BioAlliance presents AMEP preclinical, phase I clinical results for melanoma at Electrochemotherapy Meeting

FDA clears BG Medicine's Galectin-3 test to identify high risk patients with cardiovascular disease

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Latest News